Rapid Micro Biosystems, Inc. (RPID) Tops Q4 EPS by 4c, provides guidance

Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q4 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $6.34 million versus the consensus estimate of $6.15 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2024 revenue of at least $27 million, versus the consensus of $28.121 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Best Buy (BBY) Tops Q2 EPS by 12c, Offers Guidance
• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance